Renal prostacyclin biosynthesis is reduced in children with hemolytic-uremic syndrome in the context of systemic platelet activation.

[1]  G. Davı̀,et al.  Thromboxane biosynthesis and platelet function in type II diabetes mellitus. , 1990, The New England journal of medicine.

[2]  N. Perico,et al.  Renal metabolism and urinary excretion of thromboxane B2 in the rat. , 1989, The American journal of physiology.

[3]  H. Karch,et al.  Purified verotoxins of Escherichia coli O157:H7 decrease prostacyclin synthesis by endothelial cells. , 1988, Microbial pathogenesis.

[4]  T. Nokes,et al.  Intravascular platelet activation in the hemolytic uremic syndrome. , 1988, Kidney international.

[5]  P. Rose,et al.  CYTOPATHIC EFFECT OF VEROTOXIN ON ENDOTHELIAL CELLS , 1987, The Lancet.

[6]  T. Obrig,et al.  PATHOGENESIS OF HAEMOLYTIC URAEMIC SYNDROME , 1987, The Lancet.

[7]  G. Remuzzi,et al.  HUS and TTP: Variable expression of a single entity , 1987 .

[8]  K. Maeda,et al.  Urinary prostaglandins and thromboxane in patients with chronic glomerulonephritis. , 1987, Nephron.

[9]  L Roy,et al.  Platelet activation in unstable coronary disease. , 1986, The New England journal of medicine.

[10]  G. FitzGerald,et al.  Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. , 1986, British medical journal.

[11]  A. Edefonti,et al.  Intraplatelet serotonin (I5HT) in children with the hemolytic uremic syndrome. , 1985, Clinical nephrology.

[12]  A. K. Pedersen,et al.  Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. , 1984, The New England journal of medicine.

[13]  C. Patrono,et al.  Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin. , 1984, The New England journal of medicine.

[14]  T. Nokes,et al.  Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome. , 1983, Archives of disease in childhood.

[15]  J. Oates,et al.  Metabolic disposition of prostacyclin in humans. , 1983, The Journal of pharmacology and experimental therapeutics.

[16]  G. FitzGerald,et al.  Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. , 1983, Circulation.

[17]  M. Petric,et al.  SPORADIC CASES OF HAEMOLYTIC-URAEMIC SYNDROME ASSOCIATED WITH FAECAL CYTOTOXIN AND CYTOTOXIN-PRODUCING ESCHERICHIA COLI IN STOOLS , 1983, The Lancet.

[18]  G. FitzGerald,et al.  Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. , 1983, The Journal of clinical investigation.

[19]  M. Stuart,et al.  Abnormal platelet and vascular prostaglandin synthesis in an infant with hemolytic uremic syndrome. , 1983, Pediatrics.

[20]  Goldsmith Jc.  Contribution of the subendothelium to prostacyclin release after vascular injury. , 1982 .

[21]  J. S. Fong,et al.  Hemolytic-Uremic Syndrome: Current Concepts and Management , 1982 .

[22]  J. Vermylen,et al.  Abnormal prostacyclin metabolism in the hemolytic uremic syndrome: equivocal effect of prostacyclin infusions. , 1982, Clinical nephrology.

[23]  R. Ardaillou,et al.  In vitro prostaglandin synthesis by human glomeruli and papillae. , 1982, Prostaglandins.

[24]  C. Patrono,et al.  Evidence for a direct stimulatory effect of prostacyclin on renin release in man. , 1982, The Journal of clinical investigation.

[25]  J. Oates,et al.  Estimated rate of prostacyclin secretion into the circulation of normal man. , 1981, The Journal of clinical investigation.

[26]  A. Noël.  ANTI-A ISOAGGLUTININS AND PNEUMOCOCCAL VACCINE , 1981, The Lancet.

[27]  Kenneth K. Wu,et al.  ACCELERATED PROSTACYCLIN DEGRADATION IN THROMBOTIC THROMBOCYTOPENIC PURPURA , 1981, The Lancet.

[28]  L. Solomon,et al.  INHERITED PLASMA FACTOR DEFICIENCY IN HAEMOLYTIC-URAEMIC SYNDROME , 1981, The Lancet.

[29]  J. Frölich,et al.  Determination, source, metabolism, and functional role of renal prostaglandins. , 1980, Clinical and experimental hypertension.

[30]  G. Remuzzi,et al.  Treatment of the hemolytic uremic syndrome with plasma. , 1979, Clinical nephrology.

[31]  K. Solez,et al.  Prognostic importance of vascular lesions in acute renal failure with microangiopathic hemolytic anemia (hemolytic-uremic syndrome): clinicopathologic study in 20 adults. , 1979, Kidney international.

[32]  G. Remuzzi,et al.  HÆMOLYTIC-URÆMIC SYNDROME: DEFICIENCY OF PLASMA FACTOR(S) REGULATING PROSTACYCLIN ACTIVITY? , 1978, The Lancet.

[33]  R. Williams,et al.  Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. , 1978, The New England journal of medicine.

[34]  J. Pearson,et al.  Localisation and stimulation of prostacyclin production in vascular cells , 1978, Nature.

[35]  H. K. Seth.  Doctor's pay , 1977 .

[36]  J. Thomas,et al.  Haemolytic-Uraemic Syndrome in Typhoid Fever , 1974, British medical journal.

[37]  R. Fieve,et al.  Letter: How blind is the double-blind?: an assessment in a lithium-prophylaxis study. , 1974, Lancet.

[38]  L. Harker,et al.  Platelet and fibrinogen consumption in man. , 1972, The New England journal of medicine.

[39]  T. Spaet,et al.  Vascular Endothelial Damage and Thrombosis1 , 1970 .

[40]  A. Silverstein.  Thrombotic thrombocytopenic purpura. The initial neurologic manifestations. , 1968, Archives of neurology.

[41]  M. Mardiney,et al.  The vascular pathology of thrombotic thrombocytopenic purpura. An immunohistochemical and ultrastructural study. , 1966, Laboratory investigation; a journal of technical methods and pathology.

[42]  Tibbs Dj,et al.  HYPOXAEMIA AFTER ANAESTHESIA. , 1965 .

[43]  W. Symmers.  Thrombotic Microangiopathic Haemolytic Anaemia , 1952 .

[44]  Logg Mh,et al.  Para-aminosalicylic acid in tuberculosis; early results of clinical trials. , 1947 .